Gene Therapy in Parkinson Disease: From Preclinical Studies in Primates to a Phase I Clinical Trial

被引：0

作者：

Jarraya, B. ^{[1
,3
]}

Lepetit, H. ^{[3
]}

Ralph, S. ^{[2
]}

Miskin, J. ^{[2
]}

Gurruchaga, J-M ^{[3
]}

Fenelon, G. ^{[3
]}

Boulet, S. ^{[1
]}

Jan, C. ^{[1
]}

Bonvento, G. ^{[1
]}

Azzouz, M. ^{[5
]}

Brugiere, P. ^{[3
]}

Kingsman, S. ^{[2
]}

Naylor, S. ^{[2
]}

Hantraye, P. ^{[1
]}

Remy, P. ^{[1
,3
]}

Mazarakis, N. D. ^{[4
]}

Mitrophanous, K. ^{[2
]}

Palfi, S. ^{[1
,3
]}

机构：

[1] CEA CNRS MirCen, Fontenay Aux Roses, France

[2] Oxford BioMed UK Ltd, Oxford, England

[3] Univ Paris, Hop Henri Mondor, Paris, France

[4] Univ London Imperial Coll Sci Technol & Med, Div Med, Dept Gene Therapy, London SW7 2AZ, England

[5] Univ Sheffield, Sch Med, Neurol Unit, Sheffield S10 2TN, S Yorkshire, England

来源：

HUMAN GENE THERAPY | 2010年 / 21卷 / 06期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：764 / 765

页数：2

共 50 条

[41] RETROVIRAL GENE THERAPY FOR CHRONIC GRANULOMATOUS DISEASE: PRELIMINARY DATA FROM PHASE I/II TRIAL
Kim, Joong Gon
Ahn, Hyo Seop
Kang, Hyoung Jin
Kim, Sujeong
Hong, Youngtae
Joo, Chang-Wan
Yoon, Nam-Kyung
Kim, Sunyoung
JOURNAL OF GENE MEDICINE, 2009, 11 (12): : 1144 - 1144
[42] Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease: Results from an Open-Label, Phase I Trial
Muramatsu, Shin-Ichi
Fujimoto, Ken-Ichi
Kato, Seiya
Asari, Sayaka
Mizukami, Hiroaki
Ikeguchi, Kunihiko
Kawakami, Tadataka
Urabe, Masashi
Kume, Akihiro
Sato, Toshihiko
Watanabe, Eiju
Ozawa, Keiya
Nakano, Imaharu
MOLECULAR THERAPY, 2009, 17 : S168 - S168
[43] Design of clinical trials of gene therapy in Parkinson disease
Lewis, Travis B.
Standaert, David G.
EXPERIMENTAL NEUROLOGY, 2008, 209 (01) : 41 - 47
[44] Gene therapy for Parkinson disease: implications from a clinical study of AADC deficiency
Muramatsu, S.
HUMAN GENE THERAPY, 2018, 29 (12) : A19 - A20
[45] Gene therapy based delivery of GDNF in Parkinson disease patients: Are we ready for a clinical trial?
Aebischer, P.
EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 334 - 334
[46] Imaging gene expression: Preclinical studies in a primate model of Parkinson's disease
Eberling, J
Bankiewicz, KS
NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S25 - S26
[47] A phase I/II multicenter gene therapy clinical study for Fabry disease
Ganesh, Jaya
Goker-Alpan, Ozlem
Jaggumantri, Sravan
Souberbielle, Bernard
Cockroft, Bettina
MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S41 - S42
[48] A phase I/II multicenter gene therapy clinical study for Fabry disease
Hughes, Derralynn
Goker-Alpan, Ozlem
Ganesh, Jaya
Lau, Heather
Foo, Cheryl Wong Po
Souberbielle, Bernard
Woolfson, Adrian
MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S77 - S77
[49] VEGF gene therapy for angiogenesis in refractory angina: Phase I/II clinical trial
Kalil, Renato A. K.
de Salles, Felipe Borsu
Giusti, Imarilde Ines
Rodrigues, Clarissa Garcia
Han, Sang Won
Sant'Anna, Roberto Tofani
Ludwig, Eduardo
Grossman, Gabriel
Lunardi Prates, Paulo Roberto
Michelin Sant'Anna, Joao Ricardo
Teixeira Filho, Guaracy Fernandes
Nardi, Nance Beyer
Nesralla, Ivo Abrahao
REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR, 2010, 25 (03): : 311 - 321
[50] Immuno-gene therapy of human melanoma phase I/II clinical trial
Mackiewicz, A
RoseJohn, S
EUROPEAN JOURNAL OF CANCER, 1997, 33 : 34 - 34

← 1 2 3 4 5 →